Definitive Healthcare Stock Income Statements

Definitive Healthcare Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Definitive Healthcare Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30

revenue	60,750,000	59,191,000	62,288,000	62,697,000	63,737,000	63,480,000	65,932,000	65,325,000	60,957,000	59,201,000	60,599,000	57,382,000	54,548,000	50,124,000	-79,796,000	43,084,000
yoy	-4.69%	-6.76%	-5.53%	-4.02%	4.56%	7.23%	8.80%	13.84%	11.75%	18.11%	-175.94%	33.19%
qoq	2.63%	-4.97%	-0.65%	-1.63%	0.40%	-3.72%	0.93%	7.17%	2.97%	-2.31%	5.61%	5.20%	8.83%	-162.82%	-285.21%
cost of revenue:
cost of revenue exclusive of amortization	8,800,000	10,141,000	10,967,000	10,077,000	9,904,000	9,736,000	9,447,000	8,663,000	8,078,000	8,552,000	7,149,000	6,569,000	6,198,000
amortization	5,337,000	5,290,000	3,719,000	3,589,000	3,379,000	3,362,000	3,066,000	3,232,000	3,090,000	3,354,000	2,646,000	3,155,000	5,580,000	5,378,000	-7,282,000	5,356,000
gross profit	46,613,000	43,760,000	47,602,000	49,031,000	50,454,000	50,382,000	53,419,000	53,430,000	49,789,000	47,295,000	50,804,000	47,658,000	42,770,000	38,796,000	-63,287,000	32,599,000
yoy	-7.61%	-13.14%	-10.89%	-8.23%	1.34%	6.53%	5.15%	12.11%	16.41%	21.91%	-180.28%	46.19%
qoq	6.52%	-8.07%	-2.91%	-2.82%	0.14%	-5.69%	-0.02%	7.31%	5.27%	-6.91%	6.60%	11.43%	10.24%	-161.30%	-294.14%
gross margin %	76.73%	73.93%	76.42%	78.20%	79.16%	79.37%	81.02%	81.79%	81.68%	79.89%	83.84%	83.05%	78.41%	77.40%	79.31%	75.66%
operating expenses:
sales and marketing	20,469,000	20,653,000	20,372,000	20,130,000	21,545,000	21,760,000	23,605,000	22,804,000	24,702,000	23,423,000	23,523,000	21,184,000	23,585,000	21,293,000	-28,189,000	14,376,000
product development	7,968,000	9,301,000	8,982,000	7,282,000	10,122,000	10,132,000	11,569,000	10,759,000	10,229,000	9,884,000	10,129,000	9,205,000	8,706,000	6,850,000	-9,333,000	4,746,000
general and administrative	12,673,000	12,269,000	8,503,000	11,354,000	12,527,000	16,883,000	16,567,000	14,545,000	13,670,000	13,640,000	15,217,000	13,718,000	9,392,000	10,454,000	-12,526,000	7,880,000
depreciation and amortization	9,001,000	8,527,000	9,413,000	9,474,000	9,409,000	9,322,000	9,935,000	9,795,000	9,688,000	9,590,000	10,040,000	10,037,000	10,194,000	9,874,000	-6,355,000	9,760,000
transaction, integration, and restructuring expenses	672,000	1,265,000	2,835,000	-1,995,000	2,851,000	8,534,000	1,823,000	3,505,000	3,571,000	2,590,000
goodwill impairment		176,531,000	97,060,000	228,153,000	363,641,000			287,400,000
total operating expenses	50,783,000	228,546,000	147,165,000	274,398,000	420,095,000	66,631,000	63,499,000	348,808,000	61,860,000	59,127,000	60,437,000	57,089,000	53,984,000	49,781,000	-45,032,000	36,625,000
income from operations	-4,170,000	-184,786,000	-99,563,000	-225,367,000	-369,641,000	-16,249,000	-10,080,000	-295,378,000	-12,071,000	-11,832,000	-9,633,000	-9,431,000	-11,214,000	-10,985,000	-18,255,000	-4,026,000
yoy	-98.87%	1037.21%	887.73%	-23.70%	2962.22%	37.33%	4.64%	3031.99%	7.64%	7.71%	-47.23%	134.25%
qoq	-97.74%	85.60%	-55.82%	-39.03%	2174.85%	61.20%	-96.59%	2347.01%	2.02%	22.83%	2.14%	-15.90%	2.08%	-39.82%	353.43%
operating margin %	-6.86%	-312.19%	-159.84%	-359.45%	-579.95%	-25.60%	-15.29%	-452.17%	-19.80%	-19.99%	-15.90%	-16.44%	-20.56%	-21.92%	22.88%	-9.34%
other income, net:
interest income	1,749,000	2,052,000	3,206,000	3,742,000	3,717,000	3,927,000	3,774,000	3,464,000	3,572,000	2,834,000
interest expense	-2,990,000	-2,433,000	-3,509,000	-3,749,000	-3,763,000	-3,816,000	-3,899,000	-3,897,000	-3,793,000	-3,614,000	-1,483,000	-2,466,000	-2,580,000	-1,884,000	5,752,000	-7,186,000
gain on remeasurement of tax receivable agreement liability	-2,901,000	20,664,000	8,758,000	24,183,000	41,701,000	2,267,000
loss on partial extinguishment of debt		-507,000
other income	-497,000	-969,000	496,000	-357,000	-101,000	373,000	-1,982,000	29,589,000	-797,000	-3,698,000	807,000	5,528,000	4,002,000	-101,000
total other income	-4,639,000	18,807,000	8,951,000	23,819,000	41,554,000	2,751,000	-2,107,000	29,156,000	-1,018,000	-4,478,000	-676,000	3,062,000	1,422,000	-1,985,000	15,482,000	-16,940,000
net income before income taxes	-8,809,000	-165,979,000	-135,783,250	-201,548,000	-328,087,000	-13,498,000	-73,998,250	-266,222,000	-13,089,000	-16,310,000	-7,282,750	-6,369,000	-9,792,000	-12,970,000
(benefit from) benefit from income taxes	-456,000
net income	-9,265,000	-155,093,000	-84,717,000	-187,824,000	-306,187,000	-12,718,000	-13,362,000	-248,688,000	-11,605,000	-15,600,000	6,735,000	-6,354,000	-9,579,000	-13,057,000	-2,773,000	-20,966,000
yoy	-96.97%	1119.48%	534.01%	-24.47%	2538.41%	-18.47%	-298.40%	3813.88%	21.15%	19.48%	-342.88%	-69.69%
qoq	-94.03%	83.07%	-54.90%	-38.66%	2307.51%	-4.82%	-94.63%	2042.94%	-25.61%	-331.63%	-206.00%	-33.67%	-26.64%	370.86%	-86.77%
net income margin %	-15.25%	-262.02%	-136.01%	-299.57%	-480.39%	-20.03%	-20.27%	-380.69%	-19.04%	-26.35%	11.11%	-11.07%	-17.56%	-26.05%	3.48%	-48.66%
less: net income attributable to noncontrolling interests	-1,714,000	-47,865,000	-25,642,000	-56,928,000	-92,552,000	-3,200,000	-3,129,000	-77,162,000	-3,039,000	-3,783,000	-3,691,000	-3,665,000	-4,429,000	-4,433,000	-1,293,000	-5,172,000
net income attributable to definitive healthcare corp.	-7,551,000	-107,228,000	-59,075,000	-130,896,000	-213,635,000	-9,518,000	-10,233,000	-171,526,000	-8,566,000	-11,817,000	10,426,000	-2,689,000	-5,150,000	-8,624,000	-1,994,500	-7,978,000
net income per share
basic and diluted	-0.07	-0.95	-0.52	-1.12	-1.81	-0.08	-0.07	-1.5	-0.08	-0.11	0.1	-0.03	-0.05	-0.09	-0.023	-0.09
weighted-average class a common stock outstanding:
basic and diluted	106,815,740	112,782,505	116,640,183	116,382,021	117,750,392	117,433,520	112,764,537	114,527,514	111,768,782	108,234,043	101,114,105	102,904,565	99,203,697	97,158,823		88,263,333
benefit from income taxes		10,886,000	5,895,000	13,724,000	21,900,000	780,000	-1,175,000	17,534,000	1,484,000	710,000				-87,000
transaction, integration and restructuring expenses											1,590,500	2,945,000
loss on extinguishment of debt															-2,468,250	-9,873,000
income tax benefit											35,250	15,000	213,000
less: net income attributable to definitive opco prior to the reorganization transactions															-15,923,000	-7,816,000
transaction and restructuring expenses													2,107,000
cost of revenue exclusive of amortization shown below														5,950,000	-9,227,000	5,129,000
transaction expenses														1,310,000	11,371,000	-137,000
foreign currency transaction gain															35,750	119,000
weighted-average common stock outstanding:
basic and diluted	106,815,740	112,782,505	116,640,183	116,382,021	117,750,392	117,433,520	112,764,537	114,527,514	111,768,782	108,234,043	101,114,105	102,904,565	99,203,697	97,158,823		88,263,333

We provide you with 20 years income statements for Definitive Healthcare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Definitive Healthcare stock. Explore the full financial landscape of Definitive Healthcare stock with our expertly curated income statements.

The information provided in this report about Definitive Healthcare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.